from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0236c/aftD

LFCtreatmentdescriptionclass of inhibitor

0.557

Amikacinug/mL Amikacintranslation

-1.291

Cap5-10ug/mL Capreomycintranslation

-1.281

Rox10-50 ug/mL Roxithromycintranslation

-0.300

SM2-5 ug/mL Streptomycintranslation

0.706

Tet5-10 ug/mL Tetracyclinetranslation

2.161

Rif0.2-5ug/mL Rifampicintranscription

1.121

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.245

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.742

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.214

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.044

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.250

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.054

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.525

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.324

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.646

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.278

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.143

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.633

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.525

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.081

KCN5-20 ug/mL Potassium cyaniderespiration

-0.134

NaN30.2-2 mM Sodium aziderespiration

-0.630

Nigericin50 uM Nigericinrespiration

0.564

TRC10-150 ug/mL Triclosanrespiration

-0.728

TRZ10-25 ug/mL Thioridazinerespiration

-0.432

Valinomycin0.5-10 uM Valinomycinrespiration

-1.111

ZnSO42 mM ZnSO4respiration

0.341

menadione6-10 ug/mL Menadionerespiration

0.087

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.762

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.590

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.756

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.868

NRP_1Non-replicating persistence stage 1dosRassociated

-0.009

Amp0.2mg/mL AmpicillincellWall

-0.232

Cephalexin20-100 ug/mL CephalexincellWall

-0.519

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.806

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.341

EMB10-20 ug/mL EthambutolcellWall

-0.178

Eta12-40 ug/mL EthionamidecellWall

-0.393

INH0.2-0.4 ug/mL IsoniazidcellWall

0.588

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.808

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.137

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.493

BZA0.12 mg/mL BenzamidearomaticAmides

0.259

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.074

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.464

H2O24 mM hydrogen peroxideDNAdamaging

0.084

Levo10 ug/mL LevofloxacinDNAdamaging

-0.409

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.010

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.757

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.007

UVUV-irradiationDNAdamaging

1.216

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.708

Antimycin12.5-50 ug/mL Antimycin A?

0.382

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.324

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.403

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.838

PA8240.2-2 ug/mL PA-824?

0.247

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.802

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.971

Verapamil50 uM Verapamil?

0.216

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.278

methoxatin10-20 ug/mL Methoxatin?